CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 68 filers reported holding CASI PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,000 | -98.9% | 513 | -98.7% | 0.00% | – |
| Q1 2021 | $95,000 | -18.8% | 39,700 | 0.0% | 0.00% | – |
| Q4 2020 | $117,000 | +91.8% | 39,700 | 0.0% | 0.00% | – |
| Q3 2020 | $61,000 | -38.4% | 39,700 | 0.0% | 0.00% | – |
| Q2 2020 | $99,000 | +22.2% | 39,700 | 0.0% | 0.00% | – |
| Q1 2020 | $81,000 | -34.1% | 39,700 | 0.0% | 0.00% | – |
| Q4 2019 | $123,000 | -7.5% | 39,700 | 0.0% | 0.00% | – |
| Q3 2019 | $133,000 | +4.7% | 39,700 | 0.0% | 0.00% | – |
| Q2 2019 | $127,000 | +11.4% | 39,700 | 0.0% | 0.00% | – |
| Q1 2019 | $114,000 | -28.8% | 39,700 | 0.0% | 0.00% | – |
| Q4 2018 | $160,000 | -13.5% | 39,700 | 0.0% | 0.00% | – |
| Q3 2018 | $185,000 | -43.4% | 39,700 | 0.0% | 0.00% | – |
| Q2 2018 | $327,000 | – | 39,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IDG-Accel China Growth Fund III Associates L.P. | 7,973,536 | $23,522,000 | 27.18% |
| Consonance Capital Management LP | 7,576,431 | $22,350,000 | 2.09% |
| Wellington Shields & Co., LLC | 1,812,769 | $5,348,000 | 1.92% |
| Wellington Shields Capital Management, LLC | 2,071,765 | $6,112,000 | 0.82% |
| Ikarian Capital, LLC | 1,268,154 | $3,741,000 | 0.16% |
| Sio Capital Management, LLC | 203,432 | $600,000 | 0.12% |
| Zebra Capital Management LLC | 11,182 | $33,000 | 0.04% |
| FEDERATED HERMES, INC. | 7,000,000 | $20,650,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 52,146 | $154,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 161,949 | $478,000 | 0.02% |